Gujarat Themis Biosyn Limited (BOM:506879)
India · Delayed Price · Currency is INR 379.00
+4.80 (1.28%)
At close: Jul 10, 2026
Gujarat Themis Biosyn Market Cap
Gujarat Themis Biosyn has a market cap or net worth of 41.3 billion as of July 10, 2026. Its market cap has increased by 20.30% in one year.
Market Cap
41.30B
Enterprise Value
42.86B
Revenue
1.66B
Ranking
n/a
PE Ratio
88.55
Stock Price
379.00
Market Cap Chart
Since January 2, 2002, Gujarat Themis Biosyn's market cap has increased from 34.80M to 41.30B, an increase of 118,572.24%. That is a compound annual growth rate of 33.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 41.30B | -14.34% |
| Dec 31, 2025 | 48.21B | 44.85% |
| Dec 31, 2024 | 33.28B | 78.59% |
| Dec 29, 2023 | 18.64B | 65.76% |
| Dec 30, 2022 | 11.24B | 62.30% |
| Dec 31, 2021 | 6.93B | 89.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neuland Laboratories | 241.89B |
| Shilpa Medicare | 116.32B |
| Suven Life Sciences | 83.69B |
| IOL Chemicals and Pharmaceuticals | 48.42B |
| Sai Parenteral's | 25.91B |
| NGL Fine-Chem | 19.88B |
| Bajaj HealthCare | 11.23B |
| Shree Ganesh Remedies | 8.87B |